Omori Kazuhiko, Roberts Ian
Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK.
London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
J Intensive Care. 2023 Mar 22;11(1):12. doi: 10.1186/s40560-023-00661-8.
The public enquiry into the mass casualty incident at the Manchester Arena in the UK in which 23 people died and over 1000 were injured, identified the need for timely intramuscular administration of tranexamic acid to trauma patients. Since then, a number of studies and trials have been carried out and UK paramedics are now authorized to give intramuscular tranexamic acid in the pre-hospital setting. In Japan, pre-hospital administration by emergency life-saving technicians is not yet authorized, despite the fact that tranexamic acid was invented by Japanese scientists. In Japan, the need for the pre-hospital administration of tranexamic acid has been raised on several occasions, where a patient died from traumatic bleeding prior to hospital admission. This paper summarizes the evidence on the use of tranexamic acid in patients with traumatic bleeding, including new evidence on the intramuscular route.
对英国曼彻斯特竞技场发生的造成23人死亡、1000多人受伤的大规模伤亡事件进行的公开调查,确定了对创伤患者及时进行氨甲环酸肌内注射的必要性。自那时以来,已经开展了多项研究和试验,英国护理人员现在被授权在院前环境中给予氨甲环酸肌内注射。在日本,尽管氨甲环酸是由日本科学家发明的,但紧急救生技术人员在院前给药尚未得到授权。在日本,氨甲环酸院前给药的必要性已经多次被提出,曾有患者在入院前因创伤性出血死亡。本文总结了氨甲环酸在创伤性出血患者中应用的证据,包括肌内途径的新证据。